Search research articles
Contact Us
Filters
Showing results (41-50 of 50) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 50 results.
Echocardiography (Mount Kisco, N.Y.)
|
January 15, 2008
Two- and three-dimensional transthoracic and transesophageal echocardiographic findings in epithelioid hemangioma involving the mitral valve
Harvinder S Dod, Manjula V Burri, Deepak Hooda, et al.
BMC Gastroenterology
|
August 12, 2014
METRIC (MREnterography or ulTRasound in Crohn's disease): a study protocol for a multicentre, non-randomised, single-arm, prospective comparison study of magnetic resonance enterography and small bowel ultrasound compared to a reference standard in those aged 16 and over
Stuart Taylor, Susan Mallett, Gauraang Bhatnagar, et al.
Journal of Scleroderma and Related Disorders
|
June 19, 2026
Expert recommendations for the management of fecal incontinence in systemic sclerosis: A report from the World Scleroderma Foundation (WSF) Gastrointestinal "Ad hoc committee"
Zsuzsanna H McMahan, Maria Cristina De Santis, Anna Lo Cricchio, et al.
Journal of Scleroderma and Related Disorders
|
June 18, 2026
Expert recommendations for the management of refractory gastroesophageal reflux disease in systemic sclerosis: A report from the World Scleroderma Foundation (WSF) Gastrointestinal "Ad hoc committee"
Michael Hughes, Anna Lo Cricchio, Maria Cristina De Santis, et al.
Inflammatory Bowel Diseases
|
August 21, 2023
Safety, Effectiveness, and Treatment Persistence of Subcutaneous Vedolizumab in IBD: A Multicenter Study From the United Kingdom
Samuel Hsiang Lim, Beatriz Gros, Esha Sharma, et al.
Frontline Gastroenterology
|
September 3, 2020
Organisational changes and challenges for inflammatory bowel disease services in the UK during the COVID-19 pandemic
Nicholas A Kennedy, Richard Hansen, Lisa Younge, et al.
Frontline Gastroenterology
|
September 2, 2022
Comparative effectiveness of a second-line biologic in patients with ulcerative colitis: vedolizumab followed by an anti-TNF versus anti-TNF followed by vedolizumab
Charles Miller, Hanson Kwok, Paul Harrow, et al.
Gut
|
January 19, 2026
Associations between demographic, clinical and dietary factors and flares in inflammatory bowel disease: the PRognostic effect of Environmental factors in Crohn's and Colitis (PREdiCCt) prospective cohort study
Nathan Constantine-Cooke, Beatriz Gros, Nikolas Plevris, et al.
The Lancet. Gastroenterology & Hepatology
|
April 14, 2017
Mercaptopurine versus placebo to prevent recurrence of Crohn's disease after surgical resection (TOPPIC): a multicentre, double-blind, randomised controlled trial
Craig Mowat, Ian Arnott, Aiden Cahill, et al.
Journal of Crohn'S & Colitis
|
December 2, 2015
Clinical Features and HLA Association of 5-Aminosalicylate (5-ASA)-induced Nephrotoxicity in Inflammatory Bowel Disease
Graham A Heap, Kenji So, Mike Weedon, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 50) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 50 results.
Echocardiography (Mount Kisco, N.Y.)
|
January 15, 2008
Two- and three-dimensional transthoracic and transesophageal echocardiographic findings in epithelioid hemangioma involving the mitral valve
Harvinder S Dod, Manjula V Burri, Deepak Hooda, et al.
BMC Gastroenterology
|
August 12, 2014
METRIC (MREnterography or ulTRasound in Crohn's disease): a study protocol for a multicentre, non-randomised, single-arm, prospective comparison study of magnetic resonance enterography and small bowel ultrasound compared to a reference standard in those aged 16 and over
Stuart Taylor, Susan Mallett, Gauraang Bhatnagar, et al.
Journal of Scleroderma and Related Disorders
|
June 19, 2026
Expert recommendations for the management of fecal incontinence in systemic sclerosis: A report from the World Scleroderma Foundation (WSF) Gastrointestinal "Ad hoc committee"
Zsuzsanna H McMahan, Maria Cristina De Santis, Anna Lo Cricchio, et al.
Journal of Scleroderma and Related Disorders
|
June 18, 2026
Expert recommendations for the management of refractory gastroesophageal reflux disease in systemic sclerosis: A report from the World Scleroderma Foundation (WSF) Gastrointestinal "Ad hoc committee"
Michael Hughes, Anna Lo Cricchio, Maria Cristina De Santis, et al.
Inflammatory Bowel Diseases
|
August 21, 2023
Safety, Effectiveness, and Treatment Persistence of Subcutaneous Vedolizumab in IBD: A Multicenter Study From the United Kingdom
Samuel Hsiang Lim, Beatriz Gros, Esha Sharma, et al.
Frontline Gastroenterology
|
September 3, 2020
Organisational changes and challenges for inflammatory bowel disease services in the UK during the COVID-19 pandemic
Nicholas A Kennedy, Richard Hansen, Lisa Younge, et al.
Frontline Gastroenterology
|
September 2, 2022
Comparative effectiveness of a second-line biologic in patients with ulcerative colitis: vedolizumab followed by an anti-TNF versus anti-TNF followed by vedolizumab
Charles Miller, Hanson Kwok, Paul Harrow, et al.
Gut
|
January 19, 2026
Associations between demographic, clinical and dietary factors and flares in inflammatory bowel disease: the PRognostic effect of Environmental factors in Crohn's and Colitis (PREdiCCt) prospective cohort study
Nathan Constantine-Cooke, Beatriz Gros, Nikolas Plevris, et al.
The Lancet. Gastroenterology & Hepatology
|
April 14, 2017
Mercaptopurine versus placebo to prevent recurrence of Crohn's disease after surgical resection (TOPPIC): a multicentre, double-blind, randomised controlled trial
Craig Mowat, Ian Arnott, Aiden Cahill, et al.
Journal of Crohn'S & Colitis
|
December 2, 2015
Clinical Features and HLA Association of 5-Aminosalicylate (5-ASA)-induced Nephrotoxicity in Inflammatory Bowel Disease
Graham A Heap, Kenji So, Mike Weedon, et al.
Page
of 5